This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fundacion Publica Andaluza Progreso Y Salud, Servicio Andaluz De Salud. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Jordi Muntane Relat
Introduction
Jordi Muntane Relat is a notable inventor based in Seville, Spain. He has made significant contributions to the field of medical technology, particularly in the development of hemostatic agents. His innovative work focuses on improving surgical outcomes and trauma care through advanced materials.
Latest Patents
Jordi Muntane Relat holds a patent for the invention titled "Hemostatic efficacy of a nanostructured fibrin agarose hydrogel." This invention provides for nanostructured fibrin and agarose hydrogels, specifically type VII agarose hydrogels, designed as hemostatic agents. These hydrogels are intended for use as adjunct or primary treatments in cases of moderate intraoperative hemorrhage and trauma. The technology allows for topical application to wounds, ensuring rapid formation of a stable fibrin clot, which is crucial for effective hemostasis.
Career Highlights
Throughout his career, Jordi has worked with various organizations, including the Fundación Pública Andaluza Progreso y Salud and the Servicio Andaluz de Salud. His experience in these institutions has contributed to his expertise in medical innovations and research.
Collaborations
Jordi has collaborated with notable colleagues such as Rafael Campos Cuerva and Beatriz Fernández Muñoz. These partnerships have enhanced his research and development efforts in the medical field.
Conclusion
Jordi Muntane Relat's contributions to medical technology through his innovative patent demonstrate his commitment to improving patient care. His work in developing advanced hemostatic agents showcases the potential of nanostructured materials in surgical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile